Xinfuda: Pharmaceutical Packaging and Medical Device Manufacturing for GLP-1 Therapies

As GLP-1 and peptide therapies continue expanding globally, pharmaceutical companies are increasingly seeking partners that can support both pharmaceutical packaging and drug delivery device manufacturing.

Xinfuda combines dual capabilities in:

pharmaceutical primary packaging

and medical device manufacturing

supported by both:

ISO 15378

ISO 13485

This dual manufacturing structure allows Xinfuda to support the evolving needs of GLP-1, oral peptide, and biologic drug markets from both packaging and delivery system perspectives.

Pharmaceutical Packaging for Oral GLP-1 Drugs

The growth of oral GLP-1 products such as Rybelsus has increased demand for advanced moisture-protection packaging.

Oral peptide formulations are highly sensitive to humidity and environmental exposure, making packaging stability increasingly important.

desiccant bottle with CRC

Xinfuda provides:

Desiccant Bottle systems

CRC desiccant caps

High-barrier HDPE bottles

Moisture-proof pharmaceutical packaging solutions

Manufactured under ISO 15378 standards, these packaging systems help support:

pharmaceutical-grade quality management

traceability

moisture control

and stability-focused packaging performance

Medical Device Manufacturing for GLP-1 Injection Pens

At the same time, injectable GLP-1 therapies continue driving demand for reliable drug delivery devices.

reusbale pen

Products such as:

Ozempic

Wegovy

have accelerated global demand for:

disposable injection pens

reusable injection pens

and advanced self-injection systems

Under ISO 13485 manufacturing systems, Xinfuda supports medical device production focused on:

dose accuracy

device consistency

patient safety

and scalable manufacturing capability

One Supplier for Packaging and Drug Delivery Systems

As pharmaceutical companies increasingly integrate:

oral biologics

peptide drugs

injectable GLP-1 therapies

and combination drug-device platforms

the need for suppliers with both pharmaceutical packaging and medical device expertise is growing rapidly.

Xinfuda's dual identity as:

a pharmaceutical packaging manufacturer

and a medical device manufacturer

creates advantages in:

quality system alignment

regulatory support

supply chain coordination

and product development collaboration

Future of Integrated GLP-1 Solutions

The future of GLP-1 therapies will require stronger integration between:

pharmaceutical packaging

moisture-control technologies

and drug delivery devices

With expertise in both ISO15378 pharmaceutical packaging and ISO13485 medical device manufacturing, Xinfuda supports the next generation of:

oral GLP-1 packaging

peptide drug packaging

and injection pen delivery systems

for global pharmaceutical and biotech markets.